158 related articles for article (PubMed ID: 15502700)
21. α1,3Galactosyltransferase knockout pigs produce the natural anti-Gal antibody and simulate the evolutionary appearance of this antibody in primates.
Galili U
Xenotransplantation; 2013; 20(5):267-76. PubMed ID: 23968556
[TBL] [Abstract][Full Text] [Related]
22. The xenoantibody response and immunoglobulin gene expression profile of cynomolgus monkeys transplanted with hDAF-transgenic porcine hearts.
Zahorsky-Reeves JL; Kearns-Jonker MK; Lam TT; Jackson JR; Morris RE; Starnes VA; Cramer DV
Xenotransplantation; 2007 Mar; 14(2):135-44. PubMed ID: 17381688
[TBL] [Abstract][Full Text] [Related]
23. Lewis rat pancreas, but not cardiac xenografts, are resistant to anti-gal antibody mediated hyperacute rejection.
Yin DP; Sankary HN; Ma LL; Shen J; Qin Y; Blinder L; Williams JW; Chong AS
Transplantation; 2001 May; 71(10):1385-9. PubMed ID: 11391223
[TBL] [Abstract][Full Text] [Related]
24. Intact active bone transplantation synergizes with anti-CD40 ligand therapy to induce B cell tolerance.
Yin D; Ma L; Varghese A; Shen J; Chong AS
J Immunol; 2002 May; 168(10):5352-8. PubMed ID: 11994494
[TBL] [Abstract][Full Text] [Related]
25. T cell and B cell tolerance to GALalpha1,3GAL-expressing heart xenografts is achieved in alpha1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism.
Ohdan H; Yang YG; Swenson KG; Kitamura H; Sykes M
Transplantation; 2001 Jun; 71(11):1532-42. PubMed ID: 11435961
[TBL] [Abstract][Full Text] [Related]
26. ABO blood group and related antigens, natural antibodies and transplantation.
Milland J; Sandrin MS
Tissue Antigens; 2006 Dec; 68(6):459-66. PubMed ID: 17176435
[TBL] [Abstract][Full Text] [Related]
27. Antibody-Mediated Rejection in a Blood Group A-Transgenic Mouse Model of ABO-Incompatible Heart Transplantation.
Motyka B; Fisicaro N; Wang SI; Kratochvil A; Labonte K; Tao K; Pearcey J; Marshall T; Mengel M; Sis B; Fan X; dʼApice AJ; Cowan PJ; West LJ
Transplantation; 2016 Jun; 100(6):1228-37. PubMed ID: 27120451
[TBL] [Abstract][Full Text] [Related]
28. CD1d-mediated interaction between activated T cells and B cells is essential to B-cell proliferation and anti-alpha-Gal antibody production.
Liu S; Kandeva T; Tchervenkov J
Transplant Proc; 2009; 41(1):398-402. PubMed ID: 19249566
[TBL] [Abstract][Full Text] [Related]
29. One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody.
Galili U; Anaraki F; Thall A; Hill-Black C; Radic M
Blood; 1993 Oct; 82(8):2485-93. PubMed ID: 7691263
[TBL] [Abstract][Full Text] [Related]
30. Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejection.
Ohdan H; Yang YG; Shimizu A; Swenson KG; Sykes M
J Clin Invest; 1999 Aug; 104(3):281-90. PubMed ID: 10430609
[TBL] [Abstract][Full Text] [Related]
31. Intracellular expression in pig cells of anti-alpha1,3galactosyltransferase single-chain FV antibodies reduces Gal alpha1,3Gal expression and inhibits cytotoxicity mediated by anti-Gal xenoantibodies.
Vanhove B; Charreau B; Cassard A; Pourcel C; Soulillou JP
Transplantation; 1998 Dec; 66(11):1477-85. PubMed ID: 9869089
[TBL] [Abstract][Full Text] [Related]
32. Engraftment of genetically modified bone marrow cells in sensitized hosts.
Bracy J; Iacomini J
Mol Ther; 2002 Aug; 6(2):252-7. PubMed ID: 12161192
[TBL] [Abstract][Full Text] [Related]
33. Co-stimulation blockade targeting CD154 and CD28/B7 modulates the induced antibody response after a pig-to-baboon cardiac xenograft.
Wu G; Pfeiffer S; Schröder C; Zhang T; Nguyen BN; Lea W; Kelishadi S; Atkinson JB; Schuurman HJ; White DJ; Azimzadeh AM; Pierson RN
Xenotransplantation; 2005 May; 12(3):197-208. PubMed ID: 15807770
[TBL] [Abstract][Full Text] [Related]
34. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience.
Tanabe K; Takahashi K; Sonda K; Tokumoto T; Ishikawa N; Kawai T; Fuchinoue S; Oshima T; Yagisawa T; Nakazawa H; Goya N; Koga S; Kawaguchi H; Ito K; Toma H; Agishi T; Ota K
Transplantation; 1998 Jan; 65(2):224-8. PubMed ID: 9458019
[TBL] [Abstract][Full Text] [Related]
35. Autologous tumor vaccines processed to express alpha-gal epitopes: a practical approach to immunotherapy in cancer.
Galili U
Cancer Immunol Immunother; 2004 Nov; 53(11):935-45. PubMed ID: 15205919
[TBL] [Abstract][Full Text] [Related]
36. Development of B-cell memory in early childhood and the impact on antigen-specific tolerance after heart transplantation.
Urschel S; Ryan LA; M Larsen I; Biffis K; Dijke IE; West LJ
J Heart Lung Transplant; 2016 Apr; 35(4):491-9. PubMed ID: 26856666
[TBL] [Abstract][Full Text] [Related]
37. Production of anti-ABO blood group antibodies after minor ABO-incompatible bone marrow transplantation in NOD/SCID/gamma(c)(null) mice.
Tomita H; Fuchimoto Y; Mori T; Kato J; Uemura T; Handa M; Tazawa H; Ohdan H; Okamoto S; Kuroda T
Clin Transplant; 2013; 27(6):E702-8. PubMed ID: 24125194
[TBL] [Abstract][Full Text] [Related]
38. Expression of ABO or related antigenic carbohydrates on viral envelopes leads to neutralization in the presence of serum containing specific natural antibodies and complement.
Preece AF; Strahan KM; Devitt J; Yamamoto F; Gustafsson K
Blood; 2002 Apr; 99(7):2477-82. PubMed ID: 11895782
[TBL] [Abstract][Full Text] [Related]
39. Intragraft gene expression profile associated with the induction of tolerance.
Doki T; Mello M; Mock D; Evans JM; Kearns-Jonker M
BMC Immunol; 2008 Feb; 9():5. PubMed ID: 18267024
[TBL] [Abstract][Full Text] [Related]
40. In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the alpha1,3galactosyltransferase gene.
Deriy L; Ogawa H; Gao GP; Galili U
Cancer Gene Ther; 2005 Jun; 12(6):528-39. PubMed ID: 15818383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
